...
【24h】

Ultrasound mediated drug delivery: A 21st century phoenix?

机译:超声介导的药物传递:21世纪的凤凰?

获取原文
获取原文并翻译 | 示例
           

摘要

Therapeutic ultrasound is now rapidly rising, phoenix-like, from the ashes, or rather from a long period of lack of interest. The timing of this is not altogether clear, but most probably it is due to the rapid growth in interest and sophistication of imaging and molecular biology techniques. It is not widely recognised that the application of ultrasound energy to the human body was initially with therapeutic intent. Szent-Gyorgi, publishing in Nature in 1933 [1], reported that ultrasound had no effect on Ehrlich's carcinoma, but the first publication on the successful application of therapy ultrasound in human tumours was from Horvath (1944) who reported the treatment of skin metastases [2]. It was not until 1950 that John Wild [3] first reported the use of sonar pulses to look at structures within the body, thus opening up the field of medical diagnostic ultrasound, with Howry and Donaldson publishing their pioneering work later that decade [4-7].
机译:现在,治疗性超声是从灰烬中或长期以来由于缺乏兴趣而迅速上升,呈凤凰状。时机尚不完全清楚,但很可能是由于兴趣的快速增长以及成像和分子生物学技术的先进性。尚未广泛认识到,将超声能量施加到人体最初是出于治疗目的。 Szent-Gyorgi,于1933年在《自然》杂志上发表[1],报道超声对埃里希氏癌没有影响,但是成功将超声治疗应用于人类肿瘤的第一篇文献来自Horvath(1944),他报道了皮肤转移的治疗方法。 [2]。直到1950年,John Wild [3]才首次报道使用声纳脉冲观察体内结构,从而开辟了医学超声诊断领域,而Howry和Donaldson在随后的十年中发表了他们的开创性工作[4-]。 7]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号